Publicaciones en colaboración con investigadoras/es de Complejo Hospitalario Universitario Insular - Materno Infantil de Canarias (7)

2023

  1. Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 1, pp. 57-64

  2. Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years

    Actas Dermo-Sifiliograficas, Vol. 114, Núm. 4, pp. 291-298

2021

  1. Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the European Academy of Dermatology and Venereology

  2. Primary cutaneous lymphomas in children: A prospective study from the Spanish Academy of Dermatology and Venereology (AEDV) Primary Cutaneous Lymphoma Registry

    Pediatric Dermatology, Vol. 38, Núm. 6, pp. 1506-1509

2020

  1. Systemic rituximab for the treatment of the indolent forms of primary cutaneous B-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the American Academy of Dermatology, Vol. 83, Núm. 5, pp. 1535-1538

2018

  1. The First Year of the AEVD Primary Cutaneous Lymphoma Registry

    Actas Dermo-Sifiliograficas, Vol. 109, Núm. 7, pp. 610-616

2012

  1. Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: An epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma

    British Journal of Dermatology, Vol. 167, Núm. 1, pp. 174-179